4-amino-1,8-naphthalimide has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabra, DG | 1 |
| Thiyagarajan, M | 1 |
| Kaul, CL | 1 |
| Sharma, SS | 1 |
1 other study available for 4-amino-1,8-naphthalimide and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Topics: 1-Naphthylamine; Animals; Brain Chemistry; Brain Ischemia; Enzyme Inhibitors; In Situ Nick-End Label | 2004 |